Clinicians can adopt a combination of markers to stratify assessment among patients with non-ST elevation coronary syndromes which, in turn, will identify those among whom the risk of cardiac death or non-fatal myocardial infarction approaches 50 percent.
Researchers from the Department of Cardiology, St Bartholomew’s Hospital, London, England, in a prospective cohort study, determined the incremental value of clinical data, troponin T, ST segment monitoring, and heart rate variability, for predicting the outcomes.
תגובות רוצה להצטרף לדיון?
יש להתחבר כדי להגיב.
התחבראין תגובות עדיין. היה הראשון להגיב!